Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Mar 20, 2020 · 10-K · 80 days after period end · 0001171843-20-001860
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$1.61M | -$5.26M | -$5.55M | -$6.96M |
| EPS Diluted | — | -$0.27 | -$0.33 | -$0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 20, 2020 · 80 d after period end
